Sectra AB Stock
Stocks
SECT B
SE0022419784
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
03:00:00 13/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 313.80 SEK | +1.16% |
|
+5.44% | +25.02% |
| 09:20pm | Sectra Signs Service Contract With British Pathology Company Diagnexia | MT |
| 06:20pm | Sectra AB Signs Agreement With Diagnexia To Speed Up Pathology Reporting For The NHS | CI |
| Market Cap | 59.77B 5.96B 5.33B 4.97B 4.51B 8.51B 570B 8.56B 23.4B 294B 22.39B 21.89B 946B | P/E 2027 * |
80.1x | P/E 2028 * | 69.2x |
|---|---|---|---|---|---|
| Enterprise Value | 58.1B 5.79B 5.19B 4.84B 4.39B 8.27B 554B 8.32B 22.75B 286B 21.76B 21.28B 920B | EV / Sales 2027 * |
14x | EV / Sales 2028 * | 11.9x |
| Free-Float |
65.73% | Yield 2027 * |
0.64% | Yield 2028 * | 0.71% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| SECT B | Delayed | |
CBOE
| SECTBs | Real-time | |
|
Tradegate
| 61L0 | Real-time | |
|
Boerse Muenchen
| 61L0 | Real-time | |
|
CBOE
| 0A0L | Real-time | |
|
Deutsche Boerse AG
| 61L0 | Delayed | |
|
Borsa Italiana
| 1SECT | End-of-day quote | |
|
Börse Stuttgart
| 61L0 | Delayed |
Last Transcript: Sectra AB
| 1 day | +1.19% | ||
| 1 week | +5.44% | ||
| Current month | +7.39% | ||
| 1 month | +6.81% | ||
| 3 months | +9.57% | ||
| 6 months | +30.86% | ||
| Current year | +25.02% |
| 1 week | 287.8 |  | 317.6 |
| 1 month | 275.8 | | 317.6 |
| Current year | 173.3 | | 317.6 |
| 1 year | 173.3 | | 317.6 |
| 3 years | 117.1 | | 377.4 |
| 5 years | 111.4 | | 377.4 |
| 10 years | 24.8 | | 377.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 01/11/2012 | |
| Director of Finance/CFO | 50 | 20/03/2022 | |
Per Andersnäs
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/1997 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 06/09/2018 | |
| Director/Board Member | 69 | 01/01/1985 | |
Anders Persson
BRD | Director/Board Member | 73 | 01/01/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/7/26 | Sell | -13,351 | 0.0073% | |||
| 6/7/26 | Sell | -3,649 | 0.0020% | |||
| 29/4/25 | Buy | Director | 736 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | +5.44% | +3.84% | +142.32% | 5.98B | |
| +0.26% | -2.81% | +25.38% | +36.30% | 243B | |
| +0.25% | -0.38% | +7.43% | +5.20% | 155B | |
| +0.92% | +5.10% | -1.96% | +60.53% | 150B | |
| +2.47% | +3.03% | -53.99% | -10.19% | 61.93B | |
| +1.15% | -1.54% | +17.73% | +22.83% | 49.12B | |
| +1.25% | +5.82% | -16.25% | -17.42% | 48.78B | |
| +0.28% | -0.46% | +23.35% | +56.52% | 48.08B | |
| -0.49% | +3.92% | +2.96% | +36.39% | 47.95B | |
| -0.59% | -2.39% | +27.73% | +71.15% | 42.62B | |
| Average | +0.69% | +3.40% | +3.62% | +40.36% | 85.2B | |
| Weighted average by Cap. | +0.60% | +3.00% | +7.32% | +31.32% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4.16B 415M 372M 347M 314M 593M 39.7B 597M 1.63B 20.49B 1.56B 1.53B 65.93B | 4.84B 483M 432M 403M 365M 689M 46.13B 693M 1.89B 23.8B 1.81B 1.77B 76.6B |
| Net income | 746M 74.39M 66.59M 62.08M 56.3M 106M 7.11B 107M 292M 3.67B 279M 273M 11.81B | 919M 91.67M 82.06M 76.5M 69.38M 131M 8.76B 132M 360M 4.52B 344M 337M 14.55B |
| Net Debt | -1.66B -166M -148M -138M -125M -236M -15.83B -238M -650M -8.17B -622M -608M -26.29B | -2.11B -211M -189M -176M -159M -301M -20.14B -303M -827M -10.39B -791M -774M -33.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/10/26 | SEK 313.80 | +1.16% | 134,508 |
| 09/10/26 | SEK 310.20 | +3.75% | 149,912 |
| 08/10/26 | SEK 299.00 | +2.33% | 114,795 |
| 07/10/26 | SEK 292.20 | -0.81% | 908,454 |
| 06/10/26 | SEK 294.60 | -1.01% | 143,217 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SECT B Stock
Select your edition
All financial news and data tailored to specific country editions
